From Mars Rovers to Medicine: The AI Revolution with Thomas Fuchs, Chief AI Officer, Eli Lilly

What happens when the mind behind the Mars Rovers turns its attention to fighting cancer and developing next-generation medicines?Today, Thomas Fuchs is the Chief AI Officer at Eli Lilly & Company, but he started his career at NASA, building the AI that helped rovers navigate the surface of Mars. He soon realized that the same math used to distinguish sand from rocks could be used to identify cancer cells on a pathology slide. He transitioned to healthcare, coined the term "computational pathology", and secured the first-ever FDA approval for an AI solution in cancer pathology after founding Paige.ai.In this episode, Thomas joins Dr. Jurgi Camblong to discuss his journey, including how to build trust around AI, the massive potential of the technology for medicine discovery, and what the future holds for medicine.Because better outcomes don’t come from better algorithms alone—they come from pioneers brave enough to trust them.For more information on this episode follow the link below:https://www.linkedin.com/in/jurgicamblong/ https://www.sophiagenetics.com/podcasts/#AIinHealthcare #DrugDiscovery #GenerativeAI #EliLilly #DecodedPodcast